Lupin Limited has informed the Exchange regarding a press release dated August 14, 2023, titled "Lupin Receives Approval from U.S. FDA for Doxycycline Hyclate Delayed-ReleaseTablets USP.".
Lupin Limited has informed the Exchange regarding a press release dated August 14, 2023, titled "Lupin Receives Approval from U.S. FDA for Doxycycline Hyclate Delayed-ReleaseTablets USP.".